Literature DB >> 2887743

Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas.

J Gerdes, H Stein, S Pileri, M T Rivano, M Gobbi, E Ralfkiaer, K M Nielsen, G Pallesen, H Bartels, G Palestro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2887743     DOI： 10.1016/s0140-6736(87)90977-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  21 in total

Review 1.  Proliferation markers in tumours: interpretation and clinical value.

Authors:  P J van Diest; G Brugal; J P Baak
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

2.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

3.  Ki-67 Contributes to Normal Cell Cycle Progression and Inactive X Heterochromatin in p21 Checkpoint-Proficient Human Cells.

Authors:  Xiaoming Sun; Aizhan Bizhanova; Timothy D Matheson; Jun Yu; Lihua Julie Zhu; Paul D Kaufman
Journal:  Mol Cell Biol       Date:  2017-08-11       Impact factor: 4.272

4.  Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.

Authors:  S A Swanson; J J Brooks
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

Review 5.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

6.  Topoisomerase II alpha mRNA and tumour cell proliferation in non-Hodgkin's lymphoma.

Authors:  A Lohri; J Reuter; F Gudat; R Herrmann
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

7.  Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic tumor grading.

Authors:  P Kaudewitz; O Braun-Falco; M Ernst; M Landthaler; W Stolz; J Gerdes
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

8.  Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining.

Authors:  B R Schwartz; G Pinkus; S Bacus; M Toder; D S Weinberg
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

9.  Prognostic indicators in centroblastic-centrocytic lymphoma.

Authors:  N R Griffin; M R Howard; P Quirke; C J O'Brien; J A Child; C C Bird
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

10.  Determination of the growth fraction in non-Hodgkin's lymphomas by monoclonal antibody Ki-S5 directed against a formalin-resistant epitope of the Ki-67 antigen.

Authors:  H Kreipe; H H Wacker; H J Heidebrecht; K Haas; M Hauberg; M Tiemann; R Parwaresch
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.